ANDREW RODEN: Open Payments
NPI 1881145654 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 17 payments from 11 companies in 2025. Trend: 2023 $269 · 2024 $202 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 6 | $103 |
| DJO, LLC | 2 | $63 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Smith+Nephew, Inc. | 1 | $15 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: EUFLEXXA, CMF, WAINUA, VRAYLAR, XIFAXAN, CAPLYTA, Pico 14, JOURNAVX.
Industry payments across TN — which companies pay providers there.
